Eurasian Journal of Pulmonology

Scope & Guideline

Connecting clinicians and researchers for a healthier tomorrow.

Introduction

Welcome to your portal for understanding Eurasian Journal of Pulmonology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageMulti-Language
ISSN2148-3620
PublisherKARE PUBL
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEURASIAN J PULMONOL / Eurasian J. Pulmonol.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGoztepe Mah. Fahrettin Kerim Gokay Caddesi. No: 200/A D:2 Cemenzar - Kadkoy, ISTANBUL 34720, Turkiye

Aims and Scopes

The Eurasian Journal of Pulmonology focuses on advancing the understanding and management of respiratory diseases through rigorous research and clinical studies. It aims to provide a platform for the dissemination of knowledge related to various pulmonary conditions, their epidemiology, and therapeutic strategies.
  1. Epidemiology and Disease Patterns:
    The journal emphasizes studies on the epidemiology of respiratory diseases, including tuberculosis, COPD, and COVID-19, aiming to reveal patterns and trends that can inform public health strategies.
  2. Innovative Clinical Assessments:
    Research on clinical assessment tools, such as scoring systems, exercise tests, and imaging techniques, is a key focus, highlighting methodologies that improve patient evaluation and management.
  3. Therapeutic Interventions and Outcomes:
    The journal covers studies on various therapeutic approaches, including pharmacological treatments, rehabilitation techniques, and novel interventions, providing insights into their efficacy and safety.
  4. Comorbidities and Multidisciplinary Care:
    It addresses the interplay between respiratory diseases and other health conditions, advocating for a multidisciplinary approach to patient care.
  5. Patient Quality of Life and Mental Health:
    There is a growing focus on the impact of respiratory diseases on patients' quality of life and mental health, reflecting a holistic approach to pulmonary care.
The journal has identified several emerging themes reflecting current challenges and advancements in pulmonology, particularly in the context of global health crises and evolving therapeutic landscapes.
  1. Impact of COVID-19 on Lung Health:
    There is a notable increase in research related to COVID-19, including its long-term effects, management strategies, and implications for patients with pre-existing pulmonary conditions.
  2. Telemedicine and Remote Care:
    With the rise of telehealth, studies exploring remote assessments and tele-pulmonary rehabilitation are gaining traction, highlighting innovations in patient care delivery.
  3. Long-term Sequelae of Respiratory Infections:
    Emerging research focuses on the long-term consequences of respiratory infections, such as pulmonary fibrosis following COVID-19, emphasizing the need for ongoing monitoring and management.
  4. Personalized and Precision Medicine:
    The journal is seeing an increase in studies that explore personalized treatment approaches for lung diseases, utilizing biomarkers and genetic profiling to tailor interventions.
  5. Mental Health in Respiratory Disease Management:
    There is a growing emphasis on understanding the psychological impact of respiratory illnesses, leading to research on anxiety, depression, and overall mental well-being in affected patients.

Declining or Waning

While the journal has consistently covered a wide range of topics in pulmonology, certain themes have shown a decline in focus over recent years. This may reflect shifting priorities in research or changes in clinical practice.
  1. Traditional Therapeutic Approaches:
    Research on conventional treatments for respiratory diseases, such as standard pharmacotherapy protocols, appears to be waning as newer, innovative therapies gain attention.
  2. Basic Pathophysiology Studies:
    There seems to be a reduced emphasis on purely mechanistic studies of lung diseases, as the field shifts towards translational research that connects basic science with clinical application.
  3. Occupational Lung Diseases:
    The frequency of studies specifically addressing occupational lung diseases has decreased, possibly overshadowed by the urgent focus on infectious diseases and the pandemic.

Similar Journals

Therapeutic Advances in Respiratory Disease

Transforming Respiratory Medicine Through Innovation
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4658Frequency: 1 issue/year

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

Tuberculosis and Respiratory Diseases

Pioneering research for a healthier tomorrow.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Egyptian Journal of Chest Diseases and Tuberculosis

Transforming knowledge into practice for better respiratory care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Pulmonology

Advancing lung health through groundbreaking research.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Expert Review of Respiratory Medicine

Navigating the Complexities of Respiratory Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Connecting Researchers and Practitioners in Clinical Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

RESPIRATION

Fostering Collaboration for Respiratory Breakthroughs
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Tuberkuloz ve Toraks-Tuberculosis and Thorax

Fostering dialogue on thoracic health challenges.
Publisher: TURKISH ASSOC TUBERCULOSIS & THORAXISSN: 0494-1373Frequency: 4 issues/year

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

LUNG

Exploring the complexities of lung diseases for better patient outcomes.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Multidisciplinary Respiratory Medicine

Unlocking the potential of respiratory research for global impact.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.